---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-004997"
form_type: "8-K"
ticker: "NUVB"
cik: "0001811063"
company_name: "Nuvation Bio Inc."
filed_at: "2022-01-10T23:59:59+00:00"
generated_at: "2026-06-27T19:33:45.747065+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Nuvation Bio to present at JPM 2022; no specific financial or pipeline updates disclosed

## Summary
- Company conducting investor meetings at 40th Annual J.P. Morgan Healthcare Conference starting Jan 10, 2022.
- Slide presentation furnished as Exhibit 99.1 contains only a title slide; no detailed data available.
- No earnings, clinical trial results, or guidance changes announced in the filing.

## SEC filing metadata
- accession: 0001193125-22-004997
- form_type: 8-K
- ticker: NUVB
- cik: 0001811063
- company_name: Nuvation Bio Inc.
- filed_at: 2022-01-10T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1811063/000119312522004997/0001193125-22-004997-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1811063/000119312522004997/d144679d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-004997
- JSON: https://secwatch.observer/filing/0001193125-22-004997.json
- Plain text: https://secwatch.observer/filing/0001193125-22-004997.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.